Antidepressant discontinuation (withdrawal) symptoms presenting as ‘stroke’
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
We report two patients who developed a severe discontinuation (withdrawal) reaction following stoppage of paroxetine and venlafaxine, respectively. Neurological symptoms were prominent and neither patient could walk unaided. Both patients feared they had suffered a ‘stroke’ and arranged an emergency medical consultation. One patient was correctly diagnosed, the antidepressant was recommenced and symptoms resolved within 24 h. Failure to recognize the reaction resulted in the other patient being referred to a neurologist, undergoing a computed tomography brain scan and an electroencephalogram and remaining symptomatic for over 8 weeks. Relevant pharmacological issues are discussed. The cases illustrate the importance of patients and clinicians being familiar with antidepressant discontinuation symptoms.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“previous accounts have highlighted that when antidepressant withdrawal is not recognised it may be mistaken for the onset of another medical illness, including stroke, other neurological conditions, infectious disease and adverse effects of other medications the patient is taking, leading to unnecessary and expensive interventions and management.23,24”
In the citing paper
“This phenomenon has been identified before,23”
Citations
Cites
Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial
Rosenbaum, J. F., Fava, M., Hoog, S. L., Ascroft, R. C., & Krebs, W. B. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00126-7 · Cited by 574 · cited 1×
“Rosenbaum et al. (1998) recruited patients, successfully treated for depressive illness with an SSRI, and interrupted their treatment in a double-blind fashion so that they received placebo substitution for 5–8 days.”
Background5-HT and motor control: a hypothesis
Jacobs, B. L., & Fornal, C. A. (1993) · Trends in Neurosciences · doi:10.1016/0166-2236(93)90090-9 · Cited by 451
Serotonin Reuptake Inhibitor Withdrawal
Coupland, N. J., Bell, C. J., & Potokar, J. P. (1996) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199610000-00003 · Cited by 303
Emergence of Adverse Events Following Discontinuation of Treatment With Extended-Release Venlafaxine
Fava, M., Mulroy, R., Alpert, J., Nierenberg, A. A., & Rosenbaum, J. F. (1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.12.1760 · Cited by 198 · cited 2×
“In the 3 days following termination of medication, seven (78%) of nine venlafaxine-treated subjects and two (22%) of nine placebo-treated subjects reported the emergence of adverse events in response to open questioning (Fava et al., 1997).”
BackgroundWaterhouse, B. D., Ausim Azizi, S., Burne, R. A., & Woodward, D. J. (1990) · Brain Research · doi:10.1016/0006-8993(90)91422-d · Cited by 194
Michelson, D., Fava, M., Amsterdam, J., Apter, J., Londborg, P., Tamura, R., & Tepner, R. G. (2000) · British Journal of Psychiatry · doi:10.1192/bjp.176.4.363 · Cited by 181 · cited 3×
“Recent attention has focused on the selective serotonin reuptake inhibitors (SSRIs) and venlafaxine, a serotonin and noradrenalin reuptake inhibitor (SNRI).”
BackgroundInfluentialPRICE, J. S., WALLER, P. C., WOOD, S. M., & MACKAY, A. V. P. (1996) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1996.00498.x · Cited by 171
Antidepressant Withdrawal Syndrome: Recognition, Prevention and Management
Lejoyeux, M., Adès, J., Mourad, I., Solomon, J., & Dilsaver, S. C. (1996) · CNS Drugs · doi:10.2165/00023210-199605040-00006 · Cited by 136 · cited 3×
“The abrupt onset of specific symptoms (e.g. dizziness, nausea, a ‘buzzing’noise in the head, shock-like sensations) within 48 h of antidepressant stoppage is characteristic (Lejoyeux et al., 1996; Haddad, 1998).”
BackgroundThe SSRI discontinuation syndrome
Haddad, P. (1998) · Journal of Psychopharmacology · doi:10.1177/026988119801200311 · Cited by 126 · cited 4×
“The abrupt onset of specific symptoms (e.g. dizziness, nausea, a ‘buzzing’noise in the head, shock-like sensations) within 48 h of antidepressant stoppage is characteristic (Lejoyeux et al., 1996; Haddad, 1998).”
BackgroundSelf-citationMurphy, S. M., & Tyrer, P. (1991) · British Journal of Psychiatry · doi:10.1192/bjp.158.4.511 · Cited by 104
Research works printed but not linked: 3
- Australian Adverse Drug Reactions Committee, 1996, Austr Adv Drug React Bull, 15, 3
- Einbinder E, 1995, Am J Psychiatry, 152, 1253
- Haddad P, 1999, J Psychopharmacol, 13, A44
Cited by
Neurological complications of psychiatric drugs: clinical features and management
Haddad, P. M., & Dursun, S. M. (2008) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.918 · Cited by 223
“The authors have encountered patients with SSRI discontinuation syndromes who have been misdiagnosed as suffering from ‘stroke’ (Haddad et al., 2001), transient ischaemic attacks and viral labyrythitis.”
BackgroundSelf-citationAntidepressant Discontinuation Syndromes: Clinical Relevance, Prevention and Management
Haddad, P. M. (2001) · Drug Safety · doi:10.2165/00002018-200124030-00003 · Cited by 214
Self-citationFava, G. A., Benasi, G., Lucente, M., Offidani, E., Cosci, F., & Guidi, J. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000491524 · Cited by 209
Recognising and managing antidepressant discontinuation symptoms
Haddad, P. M., & Anderson, I. M. (2007) · Advances in Psychiatric Treatment · doi:10.1192/apt.bp.105.001966 · Cited by 109
“For example, case reports of SSRI discontinuation reactions have described ataxia leading to falls (Einbinder, 1995), fa tigue causing difficulty walking (Haddad et al , 2001) and electricshocklike sensations impairing walking and driving (Frost & Lal, 1995).”
Self-citationDavid, P., Kajdasz, D. K., Desaiah, D., & Haddad, P. M. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.09.003 · Cited by 89
Self-citation
Metadata
- Authors
- Haddad, P. M., Devarajan, S., & Dursun, S. M.
- Affiliations
- Cromwell House, Mental Health Services of Salford, UK
- Dalhousie University (CA)
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2001-03
- Volume
- 15
- Issue
- 2
- Pages
- 139-141
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W2023384278
- Cited by
- 25
- References
- 20
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 1 · 2022: 2 · 2021: 1 · 2020: 1 · 2018: 1
- FWCI
- 1.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Keywords
- antidepressant discontinuation syndrome, antidepressant withdrawal symptoms, paroxetine, venlafaxine, stroke mimics, neurological symptoms, misdiagnosis, differential diagnosis
- MeSH terms
- Venlafaxine Hydrochloride, Adult, Antidepressive Agents, Cyclohexanols, Diagnosis, Differential, Female, Humans, Substance Withdrawal Syndrome, Paroxetine, Antidepressive Agents, Second-Generation, Dysthymic Disorder, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antidepressant discontinuation (withdrawal) symptoms presenting as ‘stroke’. https://app.cochat.ai/papers/10.1177/026988110101500210
- The paper
- Haddad, P. M., Devarajan, S., & Dursun, S. M. (2001). Antidepressant discontinuation (withdrawal) symptoms presenting as ‘stroke’. Journal of Psychopharmacology. https://doi.org/10.1177/026988110101500210
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.